Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 4. Specific antibiotics reduce fecal biomass in mice and humans.

Published byDarrell Rich Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 4. Specific antibiotics reduce fecal biomass in mice and humans."— Presentation transcript:

1 Fig. 4. Specific antibiotics reduce fecal biomass in mice and humans.
Specific antibiotics reduce fecal biomass in mice and humans. (A) Unweighted UniFrac principal coordinates analysis of the murine fecal microbiota at baseline (day 0) and 30 days after treatment of mice orally with two nonabsorbed antibiotics (vancomycin and neomycin), PEG, or a combination of both (ABX/PEG). (B) Fecal bacterial load quantified by 16S rRNA gene copy number polymerase chain reaction (PCR) in five healthy human subjects at baseline and days 2, 3, 4, 8, and 11 during and after a 3-day treatment with three oral antibiotics (rifaximin, trimethoprim/sulfamethoxazole, and metronidazole). (C) Unweighted UniFrac principal coordinates analysis of fecal microbiota composition in the samples collected from five healthy human subjects as described in (B). (D) Fecal bacterial load quantified by 16S rRNA gene copy number PCR (per gram of stool) and anaerobic culture [colony-forming units (CFU) per gram of stool)] in healthy human subjects, who received a bowel-cleansing protocol of oral antibiotics (neomycin and vancomycin) for 72 hours and a PEG purge initiated at 36 hours. n = 5, means ± SD; statistical analysis performed using two-tailed paired Student’s t tests of log-transformed data, *P < 0.05, **P < qPCR, quatitative PCR. Josephine Ni et al., Sci Transl Med 2017;9:eaah6888 Published by AAAS

Download ppt "Fig. 4. Specific antibiotics reduce fecal biomass in mice and humans."

Similar presentations

Clostridium difficile Colitis or Dysbiosis. Symbiostasis/Dysbiosis.

Clostridium difficile Colitis or Dysbiosis. Symbiostasis/Dysbiosis.
LTB4 production is elevated in preclinical and clinical lymphedema

LTB4 production is elevated in preclinical and clinical lymphedema
Fig. 6. Sh-lantibiotics are commonly found on healthy human skin and synergize with a host AMP. Sh-lantibiotics are commonly found on healthy human skin.

Fig. 6. Sh-lantibiotics are commonly found on healthy human skin and synergize with a host AMP. Sh-lantibiotics are commonly found on healthy human skin.
Fig. 5. Protective efficacy of the combination of PGT121 + PGDM1400 against a mixed SHIV challenge in rhesus monkeys. Protective efficacy of the combination.

Fig. 5. Protective efficacy of the combination of PGT121 + PGDM1400 against a mixed SHIV challenge in rhesus monkeys. Protective efficacy of the combination.
Differentiation of AZD4785 from MAPK pathway inhibitors in vitro

Differentiation of AZD4785 from MAPK pathway inhibitors in vitro
Fig. 6. dAST directly from clinical samples using dPCR and dLAMP for quantification. dAST directly from clinical samples using dPCR and dLAMP for quantification.

Fig. 6. dAST directly from clinical samples using dPCR and dLAMP for quantification. dAST directly from clinical samples using dPCR and dLAMP for quantification.
Fig. 2. Mechanism of PD-L1 down-regulation in NOD HSPCs.

Fig. 2. Mechanism of PD-L1 down-regulation in NOD HSPCs.
Fig. 4 Bacterial taxonomic groups that discriminate among RYGB-, SHAM-, and WMS-derived samples. Bacterial taxonomic groups that discriminate among RYGB-,

Fig. 4 Bacterial taxonomic groups that discriminate among RYGB-, SHAM-, and WMS-derived samples. Bacterial taxonomic groups that discriminate among RYGB-,
Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.

Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.
Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.

Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.
Fig. 1. The effect of dietary micronutrient deficiency on the configuration of a defined human gut microbiota established in gnotobiotic mice. The effect.

Fig. 1. The effect of dietary micronutrient deficiency on the configuration of a defined human gut microbiota established in gnotobiotic mice. The effect.
Fig. 1. Anemia in patients with central diabetes insipidus.

Fig. 1. Anemia in patients with central diabetes insipidus.
Fig. 5. Performance of the MGA to enable or enhance locomotor control after SCI. Performance of the MGA to enable or enhance locomotor control after SCI.

Fig. 5. Performance of the MGA to enable or enhance locomotor control after SCI. Performance of the MGA to enable or enhance locomotor control after SCI.
Fig. 1. Associations between fecal amino acids and their derivatives with disease in pediatric patients with Crohn’s disease compared to healthy subjects.

Fig. 1. Associations between fecal amino acids and their derivatives with disease in pediatric patients with Crohn’s disease compared to healthy subjects.
Fig. 2. Associations between bacterial taxa abundance ascertained by fecal shotgun metagenomic sequencing and the fecal metabolome in healthy pediatric.

Fig. 2. Associations between bacterial taxa abundance ascertained by fecal shotgun metagenomic sequencing and the fecal metabolome in healthy pediatric.
Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.

Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.
Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.

Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.
Fig. 2. Response to repeat dosing of chimpanzees with ARC-520.

Fig. 2. Response to repeat dosing of chimpanzees with ARC-520.
Fig. 3 TLR8 signaling induces CXCL4 and IFN-α secretion by SSc PDCs.

Fig. 3 TLR8 signaling induces CXCL4 and IFN-α secretion by SSc PDCs.
Fig. 4 Topical application of SAAP-148 ointment eradicates acute and established infections of MRSA and A. baumannii from the skin. Topical application.

Fig. 4 Topical application of SAAP-148 ointment eradicates acute and established infections of MRSA and A. baumannii from the skin. Topical application.

Similar presentations

Ads by Google